Jellagen's Series B Round

Jellagen raised a round of funding on May 03, 2018.

Jellagen is a MedTech company exploiting jellyfish to provide next generation collagen biomaterials for application in 3D cell culture (in vitro diagnostics, including research level regenerative medi…

Articles about Jellagen's Series B Round: